AdaptHealth Corp.
AdaptHealth Corp.
- Market cap
- $1.01B
Your view on AHCO
Overview
What the company does, where it operates, and who runs it.
About AdaptHealth Corp.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Suzanne M. Foster
- Headquarters
- 220 West Germantown Pike, Plymouth Meeting, PA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Suzanne M. Foster
- Headquarters
- 220 West Germantown Pike, Plymouth Meeting, PA, US
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States.
The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for AdaptHealth Corp. from FRC's valuation model, read against the market price. AHCO last traded at $7.37; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for AdaptHealth Corp.. Starting points for AdaptHealth Corp.: EPS -$2.98, beta 1.36 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for AdaptHealth Corp.. Trailing twelve-month EPS for AdaptHealth Corp. stands at -$2.98. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$10.14
average of 7 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy7
- Hold0
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | −$0.04 | −$0.09 | −$0.16 | −$0.05 |
| Low estimate | −$0.04 | −$0.12 | −$0.16 | −$0.05 |
| High estimate | −$0.04 | −$0.07 | −$0.16 | −$0.04 |
| No. of analysts | 2 | 3 | 2 | 2 |
| Year-ago EPS | $0.27 | −$0.061 | −$0.521 | — |
| Growth | −116.0% | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $720.02M | $720.55M | $2.91B | $2.99B |
| Low estimate | $704.62M | $702.80M | $2.88B | $2.96B |
| High estimate | $725.99M | $728.92M | $2.96B | $3.05B |
| No. of analysts | 4 | 5 | 5 | 5 |
| Year-ago revenue | $846.29M | $819.80M | $3.24B | — |
| Growth | −14.9% | −12.1% | −10.4% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for AdaptHealth Corp.. AdaptHealth Corp. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| BBNXBeta Bionics, Inc. | Healthcare | Medical - Devices | $644.7M | ||
| ELMDElectromed, Inc. | Healthcare | Medical - Devices | $191.3M | ||
| INFUInfuSystem Holdings, Inc. | Healthcare | Medical - Devices | $293.9M | ||
| INGNInogen, Inc. | Healthcare | Medical - Devices | $144.8M | ||
| INSPInspire Medical Systems, Inc. | Healthcare | Medical - Devices | $1.7B | ||
| RMDResMed Inc. | Healthcare | Medical - Instruments & Supplies | $34.1B | ||
| TNDMTandem Diabetes Care, Inc. | Healthcare | Medical - Devices | $1.2B | ||
| VMDViemed Healthcare, Inc. | Healthcare | Medical - Care Facilities | $332.7M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CTSOCytosorbents Corporation | Healthcare | NASDAQ | $17.5M | ||
| CVCapsoVision, Inc. | Healthcare | NASDAQ | $365.6M | ||
| CVRXCVRx, Inc. | Healthcare | NASDAQ | $17.2M | ||
| CYBQFCYBERDYNE Inc. | Healthcare | OTC | $261.5M | ||
| CYBQYCYBERDYNE Inc. | Healthcare | OTC | $413.7M | ||
| CYC.AXCyclopharm Limited | Healthcare | ASX | — | ||
| CYDXCYduct Diagnostics, Inc. | Healthcare | OTC | $4.4M | ||
| DAVIDavion Healthcare Plc | Healthcare | NASDAQ | $26.8M | ||
| DCTHDelcath Systems, Inc. | Healthcare | NASDAQ | $685.3M | ||
| DGWPFDrägerwerk AG & Co. KGaA | Healthcare | OTC | $1.4B | ||
| DHAIDIH Holding US, Inc. | Healthcare | NASDAQ | — | ||
| DRORDror Ortho-Design, Inc. | Healthcare | OTC | $9.8M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| XUU.TOiShares Core S&P U.S. Total Market Index ETF | $4.6B in assets | — | |
| IJRiShares Core SP Small-Cap ETF | $103.8B in assets | 0.05% | |
| VTIVanguard Total Stock Market ETF | $689.2B in assets | 0.00% | |
| XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged) | $627M in assets | 0.03% | |
| XHSState Street SPDR S&P Health Care Services ETF | $245M in assets | 1.70% | |
| XSVMInvesco S&P SmallCap Value with Momentum ETF | $592M in assets | 0.72% | |
| RZVInvesco S&P SmallCap 600 Pure Value ETF | $285M in assets | 0.65% | |
| PSCHInvesco S&P SmallCap Health Care ETF | $188M in assets | 0.43% | |
Largest holders first, then the funds most concentrated in AHCO.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold AdaptHealth Corp., and how their positions are changing. At a $1.01B market value, institutional positions materially move AdaptHealth Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by AdaptHealth Corp. executives and directors. Shares of AdaptHealth Corp. have traded between $7.11 and $11.63 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming AdaptHealth Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for AdaptHealth Corp.. Coverage tracks AdaptHealth Corp. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of AdaptHealth Corp.